High recurrence rate of eczema herpeticum in moderate/severe atopic dermatitis: TREATgermany registry analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 21, 12, S. 1490-1498
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2023
- Event
-
Veröffentlichung
- (who)
-
Wiley
- (when)
-
2023
- Creator
-
Traidl, Stephan
Heinrich, Luise
Siegels, Doreen
Rösner, Lennart
Haufe, Eva
Harder, Inken
Abraham, Susanne
Ertner, Konstantin
Kleinheinz, Andreas
Schäkel, Knut
Wollenberg, Andreas
Effendy, Isaak
Quist, Sven
Asmussen, Andrea
Wildberger, Julia
Weisshaar, Elke
Wiemers, Franka
Brücher, Jens‐Joachim
Weidinger, Stephan
Schmitt, Jochen
Werfel, Thomas
- DOI
-
10.1111/ddg.15205
- URN
-
urn:nbn:de:bvb:384-opus4-1115403
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:52 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Traidl, Stephan
- Heinrich, Luise
- Siegels, Doreen
- Rösner, Lennart
- Haufe, Eva
- Harder, Inken
- Abraham, Susanne
- Ertner, Konstantin
- Kleinheinz, Andreas
- Schäkel, Knut
- Wollenberg, Andreas
- Effendy, Isaak
- Quist, Sven
- Asmussen, Andrea
- Wildberger, Julia
- Weisshaar, Elke
- Wiemers, Franka
- Brücher, Jens‐Joachim
- Weidinger, Stephan
- Schmitt, Jochen
- Werfel, Thomas
- Universität Augsburg
- Wiley
Time of origin
- 2023
Other Objects (12)
Update "Systemic treatment of atopic dermatitis" of the S2k‐guideline on atopic dermatitis
Essential aspects of atopic dermatitis
Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis
Atopic dermatitis : from pathognesis to treatment
Atopic dermatitis: a global health perspective
Long-Term Efficacy and Safety of Pimecrolimus Cream 1% in Adults with Moderate Atopic Dermatitis
Lebrikizumab provides rapid response in EASI components and itch in moderate-to-severe atopic dermatitis
Atopic skin diathesis rather than atopic dermatitis is associated with specific contact allergies
Pathogenesis and management of atopic dermatitis : 9 tables
S3 guideline Atopic dermatitis: part 2 ‐ systemic treatment
Characterization of regulatory T cells in atopic dermatitis
Atopic dermatitis in childhood and adolescence : 18 tables
Update "Systemic treatment of atopic dermatitis" of the S2k‐guideline on atopic dermatitis
Essential aspects of atopic dermatitis
Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis
Atopic dermatitis : from pathognesis to treatment
Atopic dermatitis: a global health perspective
Long-Term Efficacy and Safety of Pimecrolimus Cream 1% in Adults with Moderate Atopic Dermatitis
Lebrikizumab provides rapid response in EASI components and itch in moderate-to-severe atopic dermatitis
Atopic skin diathesis rather than atopic dermatitis is associated with specific contact allergies
Pathogenesis and management of atopic dermatitis : 9 tables
S3 guideline Atopic dermatitis: part 2 ‐ systemic treatment
Characterization of regulatory T cells in atopic dermatitis
Atopic dermatitis in childhood and adolescence : 18 tables
Update "Systemic treatment of atopic dermatitis" of the S2k‐guideline on atopic dermatitis
Essential aspects of atopic dermatitis
Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis
Atopic dermatitis : from pathognesis to treatment
Atopic dermatitis: a global health perspective
Long-Term Efficacy and Safety of Pimecrolimus Cream 1% in Adults with Moderate Atopic Dermatitis
Lebrikizumab provides rapid response in EASI components and itch in moderate-to-severe atopic dermatitis
Atopic skin diathesis rather than atopic dermatitis is associated with specific contact allergies
Pathogenesis and management of atopic dermatitis : 9 tables
S3 guideline Atopic dermatitis: part 2 ‐ systemic treatment
Characterization of regulatory T cells in atopic dermatitis